Main Article Content
Background and Objective: Delay in diagnosis and initiation treatment of lung cancer can affect disease progression and patient mortality, especially the patients with metastatic lung cancer. Thus, this study aimed to determine the waiting time of diagnosis and treatment in patients with stage 4 lung cancer.
Methods: This was a descriptive study that conducted the data of 268 patients with stage 4 lung cancer from the database of Srinagarind hospital between 2017 and 2018. The waiting times were reported by median with 95% confidence interval.
Results: A total of 268 stage 4 lung cancer patients, 232 patients were diagnosed that found the median waiting time for diagnosis was 28.0 days (95%CI: 23.0 to 33.4). Of those 216 patients who were received the treatment found 49.0 days (95%CI: 42.1 to 52.0). There were 155 patients who were diagnosed and received the treatment found 25.0 days (95% CI: 20.8 to 29.0) for waiting time of diagnosis to treatment.
Conclusions: The surgical diagnosed was the diagnosis method that had the longest waiting time. and the targeted therapy was the treatment method that had the longest waiting time.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Global Cancer Observatory. Lung cancer [Internet]. 2020. [cited 2020 Dec]. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/15-Lung-fact-sheet.pdf
International Agency for Research on Cancer. Lung cancer in Thailand [Internet]. 2020. [cited 2020 Dec]. Available from: https://gco.iarc.fr/today/data/factsheets/populations/764-thailand-fact-sheets.pdf
World Health Organization. Thailand: Lung Cancers [Internet]. WORLDHEALTHRANKINGS LIVE LONGER LIVE BETTER. 2020. [cited 2020 Dec]. Available from: https://www.worldlifeexpectancy.com/thailand-lung-cancers
Cancer Registry Unit, National Cancer Institute Thailand. Cancer in Thailand. 2013th–2015th ed. Vol. IX. Bangkok: 2018; 2018.
Kreetha Thammakumpee. Lung cancer textbook. Songkhla: Chanmuang press, 2007.
Cancer Unit, Faculty of Medicine Khon Kaen University. Hospital-Based Cancer Registry Srinagarind Hospital, Khon Kaen University Statistical Report 2018. Khon Kaen, Thailand: Faculty of Medicine Khon Kaen University; 2018.
Vichapat V. Prognostic factors and overall survival of advanced stage NSCLC patients in Saraburi hospital. J DMS. 2021 Jun;46(1):182–92.
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2016;11(1):39–51.
Labbé C, Anderson M, Simard S, Tremblay L, Laberge F, Vaillancourt R, et al. Wait times for diagnosis and treatment of lung cancer: a single-centre experience. Curr Oncol 2017;24(6):367–73.
Kasymjanova G, Small D, Cohen V, Jagoe RT, Batist G, Sateren W, et al. Lung cancer care trajectory at a Canadian centre: an evaluation of how wait times affect clinical outcomes. Curr Oncol 2017 ;24(5):302–9.
Evans SM, Earnest A, Bower W, Senthuren M, McLaughlin P, Stirling R. Timeliness of lung cancer care in Victoria: a retrospective cohort study. Med J Aust. 2016 Feb 1;204(2):75.
StataCorp. 2007. Stata Statistical Software: Release 10. College Station, TX: StataCorp LP.
Benbrahim Z, Zouiten O, Messoudi K, Atassi M, Amaadour L, Oualla K, et al. Wait times for diagnosis and treatment of lung cancer: Experience of the medical oncology department of Hassan II University hospital of Fez. JQSH 2019;2(3):65–9.
Khorana AA, Tullio K, Elson P, Pennell NA, Grobmyer SR, Kalady MF, et al. Time to initial cancer treatment in the United States and association with survival over time: An observational study. PLoS One 2019;14(3):e0213209.
National Cancer Institute Thailand. Guidelines for diagnosis and treatment of lung cancer. 2nd ed. Bangkok: Rongpimbuddha press, 2009.
The Comptroller General's Department adds Erlotinib to the OCPA system … [Internet]. [cited Mar 7, 2022]. Available from: https://thainews.prd.go.th/th/news/detail/TCATG201210141352520
Ha D, Ries AL, Montgrain P, Vaida F, Sheinkman S, Fuster MM. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy. Respir Med 2018;141:172–9.